Application of probiotics in adjuvant treatment of infant allergic rhinitis: A randomized controlled study

• Published in: Medicine (Baltimore) 2020-05, Vol.99 (18), p.e20095-e20095
• Main Authors: Cao, Xueqiu, Zhong, Ping, Li, Gang, Zhu, Jiao, Zheng, Yun
• Format: Article
• Language: English
• Subjects: Bifidobacterium; Child; Child, Preschool; China; Double-Blind Method; Humans; Infant; Multicenter Studies as Topic; Probiotics - administration & dosage; Probiotics - adverse effects; Probiotics - therapeutic use; Quality of Life; Randomized Controlled Trials as Topic; Rhinitis, Allergic - therapy; Severity of Illness Index; Study Protocol Clinical Trial
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000020095

Several studies have suggested that intestinal flora may play an important role in allergic diseases. The purpose of this study was to investigate the effect of probiotics of Bifidobacterium triplex on the symptoms of allergic rhinitis (AR). The effects of this probiotic on the immune system have been reported in some studies, but most previous studies have been in animals. 60 infants and young children with AR were randomly divided into 2 groups: probiotics/placebo group. The main outcome was the use of a comprehensive symptom drug score to assess allergy symptoms. In addition, health-related quality of life was investigated (rhinitis quality of life questionnaire). Secondary outcomes included a visual analog scale of allergy burden and a second quality of life questionnaire. This report describes the study design of a randomized controlled trial. The study design described a double-center, randomized, location at the Minda Hospital of Hubei Minzu University and West China Hospital of Sichuan University, which will be focused on the study about probiotics treatment and its effect on AR symptoms. It has been registered at http://www.chictr.org.cn/listbycreater.aspx (Identifier: ChiCTR2000031175), Registered March 22, 2020.